Trial Profile
The effect of sorafenib on diastolic blood pressure in patients with advanced solid tumours
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2014
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- 17 Mar 2014 Results published in the Clinical Pharmacology and Therapeutics.
- 17 Jun 2011 New trial record
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.